Terminated × Squamous Cell Carcinoma of Head and Neck × Cisplatin × Clear all ELEVATE HNSCC
Phase 2 Terminated
193 enrolled 27 charts
A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)
Phase 3 Terminated
730 enrolled 40 charts
A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy
Phase 2 Terminated
17 enrolled
A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer
Phase 1/2 Terminated
12 enrolled
Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer
Phase 2 Terminated
11 enrolled 8 charts
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer
Phase NA Terminated
8 enrolled 9 charts
Dasatinib
Phase 1 Terminated
22 enrolled 8 charts
A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.
Phase 1/2 Terminated
9 enrolled 13 charts
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
Phase 2 Terminated
47 enrolled
Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer
Phase 1 Terminated
8 enrolled
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Phase 2 Terminated
4 enrolled 4 charts
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
Phase 2 Terminated
7 enrolled 6 charts
Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 1 Terminated
1 enrolled
Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil
Phase 2 Terminated
14 enrolled 8 charts
Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
Phase 2 Terminated
6 enrolled 5 charts
Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer
Phase 2 Terminated
34 enrolled 5 charts
SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue
Phase 2 Terminated
68 enrolled
Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy
Phase 2 Terminated
18 enrolled 8 charts
EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase 1 Terminated
13 enrolled
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
Phase 3 Terminated
15 enrolled 5 charts
RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer
Phase 1 Terminated
3 enrolled
Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 1 Terminated
30 enrolled
Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase 1/2 Terminated
11 enrolled
S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx
Phase 3 Terminated
6 enrolled
S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat
Phase 2 Terminated
13 enrolled
Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer
Phase 1/2 Terminated
29 enrolled